290 related articles for article (PubMed ID: 24103254)
1. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of MDMA and methylphenidate on social cognition.
Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Dolder PC; Müller F; Schmid Y; Borgwardt SJ; Liechti ME
Psychopharmacology (Berl); 2018 Feb; 235(2):467-479. PubMed ID: 28551715
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.
Schmid Y; Hysek CM; Preller KH; Bosch OG; Bilderbeck AC; Rogers RD; Quednow BB; Liechti ME
Eur Neuropsychopharmacol; 2015 Jan; 25(1):17-25. PubMed ID: 25498417
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.
Seibert J; Hysek CM; Penno CA; Schmid Y; Kratschmar DV; Liechti ME; Odermatt A
Neuroendocrinology; 2014; 100(1):17-25. PubMed ID: 24903002
[TBL] [Abstract][Full Text] [Related]
6. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.
Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S
Int J Neuropsychopharmacol; 2018 Apr; 21(4):345-354. PubMed ID: 29206921
[TBL] [Abstract][Full Text] [Related]
7. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S
Int J Neuropsychopharmacol; 2017 Sep; 20(9):712-720. PubMed ID: 28525569
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
[TBL] [Abstract][Full Text] [Related]
10. Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Schmid Y; Rickli A; Schaffner A; Duthaler U; Grouzmann E; Hysek CM; Liechti ME
J Pharmacol Exp Ther; 2015 Apr; 353(1):102-11. PubMed ID: 25655950
[TBL] [Abstract][Full Text] [Related]
11. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
[TBL] [Abstract][Full Text] [Related]
12. MDMA enhances emotional empathy and prosocial behavior.
Hysek CM; Schmid Y; Simmler LD; Domes G; Heinrichs M; Eisenegger C; Preller KH; Quednow BB; Liechti ME
Soc Cogn Affect Neurosci; 2014 Nov; 9(11):1645-52. PubMed ID: 24097374
[TBL] [Abstract][Full Text] [Related]
13. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Hysek CM; Simmler LD; Ineichen M; Grouzmann E; Hoener MC; Brenneisen R; Huwyler J; Liechti ME
Clin Pharmacol Ther; 2011 Aug; 90(2):246-55. PubMed ID: 21677639
[TBL] [Abstract][Full Text] [Related]
14. Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.
Mori T; Uzawa N; Kazawa H; Watanabe H; Mochizuki A; Shibasaki M; Yoshizawa K; Higashiyama K; Suzuki T
J Pharmacol Exp Ther; 2014 Aug; 350(2):403-11. PubMed ID: 24917544
[TBL] [Abstract][Full Text] [Related]
15. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants.
Straumann I; Ley L; Holze F; Becker AM; Klaiber A; Wey K; Duthaler U; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2023 Dec; 48(13):1840-1848. PubMed ID: 37258715
[TBL] [Abstract][Full Text] [Related]
17. Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek CM; Brugger R; Simmler LD; Bruggisser M; Donzelli M; Grouzmann E; Hoener MC; Liechti ME
J Pharmacol Exp Ther; 2012 Feb; 340(2):286-94. PubMed ID: 22034656
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
Mas M; Farré M; de la Torre R; Roset PN; Ortuño J; Segura J; Camí J
J Pharmacol Exp Ther; 1999 Jul; 290(1):136-45. PubMed ID: 10381769
[TBL] [Abstract][Full Text] [Related]
19. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
